A
Arbutus Biopharma Corporation (ABUS)
NMS – Real vaqt narxi. Valyuta: USD
4.58
+0.17 (3.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.65
+0.07 (1.53%)
Bozordan keyin: Jun 26, 2026, 6:14 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
4.58
+0.17 (3.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.65
+0.07 (1.53%)
Bozordan keyin: Jun 26, 2026, 6:14 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $23.7M umumiy qarzdan $3.9M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $277.0M jami joriy majburiyatlardan $5.1M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (9948x) kompaniya qarz to'lovlarini osonlik bilan boshqarishini ko'rsatadi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 54.26 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 54.26 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.01 | 0.30 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.01 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | 9948.06 | -16.91 | 10 | |
| O‘rtacha ball | 9.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 39M | 18M | 6M | 14M | 191M |
| Yalpi foyda | 38M | 17M | 5M | 14M | 191M |
| Operatsion daromad | -63M | -78M | -70M | -27M | 155M |
| Sof foyda | -69M | -73M | -70M | -34M | 161M |
| EBITDA | -62M | -77M | -69M | -27M | 155M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | -93.48 | -300 | 1.0 |
| Keyingi chorak | 28.73 | 50 | 10 |
| Joriy yil | 1186.66 | 541.18 | 10 |
| Keyingi yil | -98.51 | -112 | 1.0 |
| O‘rtacha ball | 5.5 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 16943.39 | 4617.97 | 8800 | 27.63 | 10 |
| Yil/Yil | 10054.54 | 791.9 | 769.23 | 54.15 | 10 |
| 3 yil o‘rtacha | 2.91 | 17.08 | 24.42 | -26.04 | 6.0 |
| 5 yil o‘rtacha | 64.55 | 8.11 | 26.97 | -12.56 | 6.8 |
| O‘rtacha ball | 8.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |